CMS Will Cover Warfarin Gene Tests In Clinical Trials, But That's It
This article was originally published in The Gray Sheet
Executive Summary
Medicare will only cover genetic testing for individual response to the blood-thinner warfarin in the context of controlled clinical studies, effective immediately, CMS said Aug. 3